drugset
drugset / Trial / NCT05184348

Plexin B2 Gene Expression and Polymorphisms in Psoriasis

NCT05184348 ↗

Phase 1 Completed 200 enrolled South Valley University
RandomizedParallel-groupSingle-blindTreatment

Summary

Patients will be randomly assigned (1:1:1 ) either to ; NB-UVB photo-therapy alone , Acitretin therapy alone or NB-UVB photo-therapy combined with Acitretin therapy randomization will be done by closed envelopes . investigator will be blinded to study drug assignment , while patients and data interpreter will not be masked to study drug assignment.

Timeline

Start
2021-09-01
Primary completion
2023-01-30
Completion
2023-03-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Acitretin Small molecule 0.5 mg/kg Oral
Comparator Acitretin Small molecule 1 mg/kg Oral

Indications

psoriasis